Titan Pharmaceuticals to Present at 28th Annual ROTH Conference
SOUTH SAN FRANCISCO, CA -- (Marketwired) -- 03/08/16 -- Titan Pharmaceuticals, Inc. (NASDAQ: TTNP), a specialty pharmaceutical company developing proprietary therapeutics for the treatment of select chronic diseases utilizing its ProNeura™ long-term, …